Thus, it appears that SHOC2 acts as an oncogene by activating the RAS/MAPK or a tumor suppressor by inactivating the mTORC1 signals, respectively, to regulate the growth and survival, and liver tumorigenesis. This evidence concerns the gene SHOC2 and neoplasm.